Well Health Technologies Stock Return On Asset

WELL Stock  CAD 5.86  0.31  5.59%   
WELL Health Technologies fundamentals help investors to digest information that contributes to WELL Health's financial success or failures. It also enables traders to predict the movement of WELL Stock. The fundamental analysis module provides a way to measure WELL Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WELL Health stock.
As of the 1st of December 2024, Return On Assets is likely to grow to 0.000061.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

WELL Health Technologies Company Return On Asset Analysis

WELL Health's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current WELL Health Return On Asset

    
  0.0245  
Most of WELL Health's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WELL Health Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

WELL Return On Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for WELL Health is extremely important. It helps to project a fair market value of WELL Stock properly, considering its historical fundamentals such as Return On Asset. Since WELL Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of WELL Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of WELL Health's interrelated accounts and indicators.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

WELL Total Assets

Total Assets

1.48 Billion

At this time, WELL Health's Total Assets are very stable compared to the past year.
Based on the latest financial disclosure, WELL Health Technologies has a Return On Asset of 0.0245. This is 100.28% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on asset for all Canada stocks is 117.5% lower than that of the firm.

WELL Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses WELL Health's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of WELL Health could also be used in its relative valuation, which is a method of valuing WELL Health by comparing valuation metrics of similar companies.
WELL Health is currently under evaluation in return on asset category among its peers.

WELL Health Current Valuation Drivers

We derive many important indicators used in calculating different scores of WELL Health from analyzing WELL Health's financial statements. These drivers represent accounts that assess WELL Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of WELL Health's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap151.2M1.1B937.3M626.8M910.7M956.2M
Enterprise Value154.7M1.0B1.3B936.3M1.3B1.4B

WELL Fundamentals

About WELL Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze WELL Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WELL Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WELL Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Other Information on Investing in WELL Stock

WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.